Literature DB >> 20519390

Transcription factor YY1 interacts with retroviral integrases and facilitates integration of moloney murine leukemia virus cDNA into the host chromosomes.

Yujin Inayoshi1, Yuuki Okino, Katsuhide Miyake, Akifumi Mizutani, Junko Yamamoto-Kishikawa, Yuya Kinoshita, Yusuke Morimoto, Kazuhito Imamura, Mahboob Morshed, Ken Kono, Toshinari Itoh, Ken-ichi Nishijima, Shinji Iijima.   

Abstract

Retroviral integrases associate during the early viral life cycle with preintegration complexes that catalyze the integration of reverse-transcribed viral cDNA into the host chromosomes. Several cellular and viral proteins have been reported to be incorporated in the preintegration complex. This study demonstrates that transcription factor Yin Yang 1 binds to Moloney murine leukemia virus, human immunodeficiency virus type 1, and avian sarcoma virus integrases. The results of coimmunoprecipitation and in vitro pulldown assays revealed that Yin Yang 1 interacted with the catalytic core and C-terminal domains of Moloney murine leukemia virus and human immunodeficiency virus type 1 integrases, while the transcriptional repression and DNA-binding domains of the Yin Yang 1 molecule interacted with Moloney murine leukemia virus integrase. Immunoprecipitation of the cytoplasmic fraction of virus-infected cells followed by Southern blotting and chromatin immunoprecipitation demonstrated that Yin Yang 1 associated with Moloney murine leukemia virus cDNA in virus-infected cells. Yin Yang 1 enhanced the in vitro integrase activity of Moloney murine leukemia virus, human immunodeficiency virus type 1, and avian sarcoma virus integrases. Furthermore, knockdown of Yin Yang 1 in host cells by small interfering RNA reduced Moloney murine leukemia virus cDNA integration in vivo, although viral cDNA synthesis was increased, suggesting that Yin Yang 1 facilitates integration events in vivo. Taking these results together, Yin Yang 1 appears to be involved in integration events during the early viral life cycle, possibly as an enhancer of integration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20519390      PMCID: PMC2916549          DOI: 10.1128/JVI.02681-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  YY1AP, a novel co-activator of YY1.

Authors:  Chen-Yu Wang; Yuh-Jin Liang; Young-Sun Lin; Hsiu-Ming Shih; Yuh-Shan Jou; Winston C Y Yu
Journal:  J Biol Chem       Date:  2004-01-26       Impact factor: 5.157

2.  The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation.

Authors:  Giuseppina Caretti; Monica Di Padova; Bruce Micales; Gary E Lyons; Vittorio Sartorelli
Journal:  Genes Dev       Date:  2004-11-01       Impact factor: 11.361

3.  The cellular protein daxx interacts with avian sarcoma virus integrase and viral DNA to repress viral transcription.

Authors:  James G Greger; Richard A Katz; Alexander M Ishov; Gerd G Maul; Anna Marie Skalka
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses.

Authors:  David Derse; Bruce Crise; Yuan Li; Gerald Princler; Nicole Lum; Claudia Stewart; Connor F McGrath; Stephen H Hughes; David J Munroe; Xiaolin Wu
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

5.  Differential multimerization of Moloney murine leukemia virus integrase purified under nondenaturing conditions.

Authors:  Rodrigo A Villanueva; Colleen B Jonsson; Jennifer Jones; Millie M Georgiadis; Monica J Roth
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

6.  High-level expression of single-chain Fv-Fc fusion protein in serum and egg white of genetically manipulated chickens by using a retroviral vector.

Authors:  Masamichi Kamihira; Ken-ichiro Ono; Kazuhisa Esaka; Ken-ichi Nishijima; Ryoko Kigaku; Hiroyuki Komatsu; Takashi Yamashita; Kenji Kyogoku; Shinji Iijima
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 7.  BAF: roles in chromatin, nuclear structure and retrovirus integration.

Authors:  Miriam Segura-Totten; Katherine L Wilson
Journal:  Trends Cell Biol       Date:  2004-05       Impact factor: 20.808

8.  Transcription start regions in the human genome are favored targets for MLV integration.

Authors:  Xiaolin Wu; Yuan Li; Bruce Crise; Shawn M Burgess
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

9.  Integration of murine leukemia virus DNA depends on mitosis.

Authors:  T Roe; T C Reynolds; G Yu; P O Brown
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

10.  Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors.

Authors:  Barbara Studamire; Stephen P Goff
Journal:  Retrovirology       Date:  2008-06-13       Impact factor: 4.602

View more
  5 in total

Review 1.  The oncogenic role of Yin Yang 1.

Authors:  Qiang Zhang; Daniel B Stovall; Kazushi Inoue; Guangchao Sui
Journal:  Crit Rev Oncog       Date:  2011

2.  PRMT5 epigenetically regulates the E3 ubiquitin ligase ITCH to influence lipid accumulation during mycobacterial infection.

Authors:  Salik Miskat Borbora; Raju S Rajmani; Kithiganahalli Narayanaswamy Balaji
Journal:  PLoS Pathog       Date:  2022-06-03       Impact factor: 7.464

3.  Knockdown of the cellular protein LRPPRC attenuates HIV-1 infection.

Authors:  Cameron J Schweitzer; John M Matthews; Christian J Madson; Meghan R Donnellan; Ronald L Cerny; Michael Belshan
Journal:  PLoS One       Date:  2012-07-12       Impact factor: 3.240

Review 4.  HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection.

Authors:  Charles R M Bangham; Lucy B Cook; Anat Melamed
Journal:  Semin Cancer Biol       Date:  2013-12-06       Impact factor: 15.707

Review 5.  Dual Role of YY1 in HPV Life Cycle and Cervical Cancer Development.

Authors:  Alicja Warowicka; Justyna Broniarczyk; Martyna Węglewska; Wojciech Kwaśniewski; Anna Goździcka-Józefiak
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.